Holen Sie sich die Stockscreener-App
2.2001
8.71%
-0.21
Handel nachbörslich:
2.20
-0.000100
-0.00%
Schlusskurs vom Vortag:
$2.4101
Offen:
$2.3
24-Stunden-Volumen:
1,039
Relative Volume:
0.05
Marktkapitalisierung:
$5.41M
Einnahmen:
$453.80K
Nettoeinkommen (Verlust:
$-1.03M
KGV:
-3.0625
EPS:
-0.7184
Netto-Cashflow:
-
1W Leistung:
-8.33%
1M Leistung:
-15.38%
6M Leistung:
-18.82%
1J Leistung:
-88.44%
1-Tages-Spanne:
$2.2001
$2.43
1-Wochen-Bereich:
$2.1859
$2.50
52-Wochen-Spanne:
$2.0101
$41.12
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile
Firmenname
X T L Biopharmaceuticals Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare XTLB vs VRTX, REGN, MRNA, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XTLB
X T L Biopharmaceuticals Ltd Adr
|
2.2001 | 5.41M | 453.80K | -1.03M | 0 | -0.7184 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2015-05-08 | Eingeleitet | H.C. Wainwright | Buy |
X T L Biopharmaceuticals Ltd Adr Aktie (XTLB) Neueste Nachrichten
XTL Biopharmaceuticals (XTLB) Trades Flat at $2.56, Sitting Midway Between Support and ResistanceLiquidity Sweep - dars.gov.et
XTL Biopharmaceuticals Faces Derivative Action Bid Over Failed Social Proxy Acquisition - TipRanks
XTL Biopharmaceuticals Ltd. Sponsored ADR Revenue Breakdown – FWB:HHB0 - TradingView
XTL Biopharmaceuticals Regains Nasdaq Compliance and Enters One-Year Monitoring Period - The Globe and Mail
XTLB Stock Price, Quote & Chart - ChartMill
Enterprise value to EBITDA forward of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView
XTL Biopharmaceuticals Completes Psyga Bio Acquisition, Refocuses on Psychedelic Medicine - TipRanks
XTL Biopharmaceuticals Shareholders Approve Psyga Bio Acquisition and Major Capital Increase - TipRanks
Wondering what's happening in today's after-hours session? - ChartMill
XTL Biopharmaceuticals Adjourns Extraordinary Shareholder Meeting to June 29, 2026 - TipRanks
XTL Biopharmaceuticals (XTLB) Stock Price, News & Analysis $XTLB - MarketBeat
XTLB - Finviz
XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report - TipRanks
XTL Biopharmaceuticals faces additional Nasdaq delisting risk - Investing.com
Eastern International Ltd. expands board, appoints two new directors - Investing.com
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise - The Globe and Mail
SMX increases authorized shares for incentive plan and grants restricted stock units - Investing.com
XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal - TipRanks
XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation - TipRanks
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.57% - Investing.com
XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline - TipRanks
XTL Biopharmaceuticals to acquire Psyga Bio for 40% stake - Investing.com
Triangle DescendingStock ScreenerCharts - Finviz
Top GainersStock ScreenerSnapshot - Finviz
XTL Biopharmaceuticals Ltd ADR Each REPR 40 share price | XTLB - Hargreaves Lansdown
Debt to assets ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:HHB0 - TradingView
Total assets of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView
Return on invested capital % of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView
Free cash flow per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:HHB0 - TradingView
Tangible book value per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Trade Ideas — SWB:HHB0 - TradingView
Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Cash Flow – LSX:A41X7J - TradingView
Average basic shares outstanding of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView
Total operating expenses of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView — Track All Markets
Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView
EBITDA margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – LSX:A41X7J - TradingView
Return on assets % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView
Basic earnings per share (basic EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView — Track All Markets
XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – LS:A41X7J - TradingView
Price to cash flow ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:A41X7J - TradingView
Revenue per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:A41X7J - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – GETTEX:A41X7J - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Balance Sheet – MUN:HHB0 - TradingView
Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView
Total operating expenses of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView
Gross margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView
Long term debt to total equity ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView
Price to sales ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView
Return on invested capital % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView
Finanzdaten der X T L Biopharmaceuticals Ltd Adr-Aktie (XTLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.06%
2.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):